# Nesiritide and Renal Function After the Total Artificial Heart

> **NCT01836809** · PHASE4 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 2 (actual)

## Conditions studied

- Congestive Heart Failure
- Cardiorenal Syndrome

## Interventions

- **DRUG:** nesiritide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01836809
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Futility for enrollment
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836809, "Nesiritide and Renal Function After the Total Artificial Heart". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01836809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*